Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyridazine compounds >  1-(6-Chloro-3-pyridazinyl)-4-piperidinol

1-(6-Chloro-3-pyridazinyl)-4-piperidinol

Basic information Safety Supplier Related

1-(6-Chloro-3-pyridazinyl)-4-piperidinol Basic information

Product Name:
1-(6-Chloro-3-pyridazinyl)-4-piperidinol
Synonyms:
  • 1-(6-Chloro-3-pyridazinyl)piperidin-4-ol
  • 1-(6-CHLORO-3-PYRIDAZINYL)-4-PIPERIDINOL
  • 1-(6-CHLOROPYRIDAZIN-3-YL)PIPERIDIN-4-OL
  • 1-(6-Chloropyridazin-3-yl)piperidin-4-ol95%
  • 1-(6-Chloro-pyridazino-3-yl)-4-hydroxypiperidine
  • 1-(6-Chloropyridazin-3-yl)-4-hydroxypiperidine
  • 4-Piperidinol, 1-(6-chloro-3-pyridazinyl)-
  • 1-(6-Chloro-3-pyridazinyl)-4-piperidinol ISO 9001:2015 REACH
CAS:
89937-26-8
MF:
C9H12ClN3O
MW:
213.66
Mol File:
89937-26-8.mol
More
Less

1-(6-Chloro-3-pyridazinyl)-4-piperidinol Chemical Properties

Boiling point:
453.3±45.0 °C(Predicted)
Density 
1.360±0.06 g/cm3(Predicted)
storage temp. 
Inert atmosphere,Room Temperature
form 
solid
pka
14.52±0.20(Predicted)
More
Less

Safety Information

Hazard Codes 
Xn
Risk Statements 
22
More
Less

1-(6-Chloro-3-pyridazinyl)-4-piperidinol Usage And Synthesis

Synthesis

5382-16-1

141-30-0

89937-26-8

General procedure: 3,6-dichloropyridazine (1 eq.), 4-hydroxypiperidine (1 eq.) and a nonprotonic base (e.g., Et3N or K2CO3, 2-3 eq.) are dissolved in DMSO or EtOH in a sealed vessel, and the reaction is heated until the feedstocks are shown to be completely consumed by TLC or HPLC monitoring. Upon completion of the reaction, post-treatment is carried out: the reaction mixture is partially evaporated, followed by the addition of water and filtration to collect the precipitated solid product (for cases such as 37); alternatively, the partially evaporated reaction mixture is partitioned between EtOAc and water, and the aqueous layer is extracted with EtOAc several times to ensure complete extraction. The organic layers are combined, dried over anhydrous Na2SO4 and concentrated under reduced pressure to give the crude product, which is finally purified by column chromatography.

References

[1] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 8, p. 1819 - 1839
[2] Patent: WO2016/54388, 2016, A1. Location in patent: Page/Page column 57
[3] Journal of Medicinal Chemistry, 1984, vol. 27, # 8, p. 1077 - 1083
[4] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 24, p. 7281 - 7286
[5] Patent: WO2008/46226, 2008, A1. Location in patent: Page/Page column 42

1-(6-Chloro-3-pyridazinyl)-4-piperidinolSupplier

Energy Chemical
Tel
021-021-58432009 400-005-6266
Email
sales8178@energy-chemical.com
Wuhan Chemwish Technology Co., Ltd
Tel
86-027-67849912
Email
sales@chemwish.com
Nanjing Norris-Pharm Technology Co., Ltd
Tel
18652989687
Email
sales@norris-pharm.com
Suzhou APIC Biotechnology Co., Ltd.
Tel
0512-65757861-8000
Email
sales@apiclab.cn
Cool Pharm, Ltd
Tel
021-60455363 18019463053
Email
sales@coolpharm.com